Singapore: IPOS launches free deferment of patent prosecution as pilot initiative

In response to the growing interests of applicants in having more time to decide how best to prosecute their Singapore patent applications in alignment with their global patenting strategies and IP commercialization developments, the Intellectual Property Office of Singapore (IPOS) has launched a pilot initiative to allow eligible applicants to defer the filings of request […]

India- What constitutes ‘therapeutic efficacy’ when determining patentability of ‘new forms of known substances’

The Delhi High Court recently rendered a significant decision clarifying the concept of enhanced therapeutic efficacy, when determining the patentability of new forms of known substances. The case involved an appeal by the patent applicant challenging the rejection of their patent application under Section 3(d) of the Patents Act, 1970 (as amended) (the ‘Act’). Section […]

New Singapore Patent Fast Track Programme to Accelerate Patent Prosecution Timeframe

The Intellectual Property Office of Singapore (IPOS) in its continuing effort to expand support to innovators, launched a new programme named the “SG Patent Fast Track”  on 4 May 2020 to replace the existing patent acceleration programmes, namely FinTech Fast Track and Accelerated Initiative for Artificial Intelligence (“AI2”), which ceased on 25 April 2020 and […]